# Momenta Pharmaceuticals, Inc. – FDA Inspection, May 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/momenta-pharmaceuticals-inc/6169cbb0-b8d2-48ee-bf15-2a27dd732f1f
Source feed: FDA_Inspections

> FDA inspection 1015902 of Momenta Pharmaceuticals, Inc., May 15, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015902
- Company Name: Momenta Pharmaceuticals, Inc.
- Inspection Date: 2017-05-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 874279 - 2014-04-11
- FDA Inspection 786187 - 2012-06-08
- FDA Inspection 630475 - 2009-11-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)
- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)

Company: https://www.keypedia.com/companies/momenta-pharmaceuticals-inc/c21f791e-0071-4f33-81c2-32205123a6cd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c